Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06115772 · ClinicalTrials.gov registry record
Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study
A clinical trial of Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 154
- Enrollment target
- 1
- Study location
NCT06115772 is a study of Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 154 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06115772, a study of Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 154 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2027-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06115772
The ClinicalTrials.gov registry entry for NCT06115772 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06115772 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06115772 about?
NCT06115772 is a clinical study titled "Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study". This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).
What is the current status of trial NCT06115772?
This trial is currently recruiting. The enrollment target is 154 participants. The study started on 2022-11-01. Estimated completion is 2027-11-01.
What conditions does trial NCT06115772 study?
This clinical trial studies the following conditions: Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma.
What interventions are being tested in trial NCT06115772?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06115772?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06115772 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.